Clinical trial

N-of-1 for Beta-Blockers in Cardiac Amyloidosis

NCT05019027

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Beta blocker Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

N-of-1 for Beta-Blockers in Cardiac Amyloidosis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-01-31

PhasePHASE4

Conditions

Cardiac Amyloidosisunresolved

Heart Diseasesunresolved

TTR Cardiac Amyloidosisunresolved

Interventions

Beta blockerDRUG

Sponsors & collaborators

Weill Medical College of Cornell Universitylead sponsor

U.S. Deprescribing Research Networkcollaborator

National Institute on Aging (NIA)collaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05019027 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.